Western blot analysis on A431 cell lysates using anti-Phospho-IkappaB-alpha (pY42) RabMAb (Cat. #AJ1389c). Cells were either (A) untreated (B) treated with pervanadate.
Inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL dimers in the cytoplasm through masking of their nuclear localization signals. On cellular stimulation by immune and proinflammatory responses, becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription
Tissue Specificity
A synthetic peptide corresponding to residues surrounding Tyrosine 42 of human IKappaB-alpha was used as an immunogen.
Cellular Localization
Cytoplasm. Nucleus. Note=Shuttles between the nucleus and the cytoplasm by a nuclear localization signal (NLS) and a CRM1-dependent nuclear export (By similarity)
Western blot analysis on A431 cell lysates using anti-Phospho-IkappaB-alpha (pY42) RabMAb (Cat. #AJ1389c). Cells were either (A) untreated (B) treated with pervanadate.
Application Notes
WB:1:500~1000
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.